The Gut Metabolite Trimethylamine N-Oxide Is Associated With Parkinson's Disease Severity and Progression
Journal
Movement Disorders
Date Issued
2020
Author(s)
Chen S.-J.
Kuo H.-C.
Abstract
Appendix S1 Supplementary Methods TABLE S1. Clinical characteristics of study participants TABLE S2. Cox regression analysis of baseline trimethylamine N-oxide levels and motor or cognition progression in patients with Parkinson's disease Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
SDGs
Other Subjects
trimethylamine oxide; methylamine; trimethyloxamine; controlled study; disease exacerbation; disease severity; human; major clinical study; Note; Parkinson disease; priority journal; intestine flora; severity of illness index; Gastrointestinal Microbiome; Humans; Methylamines; Parkinson Disease; Severity of Illness Index
Publisher
John Wiley and Sons Inc.
Type
note